Nexsen Limited (ASX: NXN)
Health Care · Biotechnology · AU
AU$0.14
+7.69% today · -49.1% 1Y
Nexsen Limited (ASX: NXN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $19.50M.
Over the last twelve months the share price has lost 49.1%, trading between 0.11 and 0.35.
Tweenvest scores Nexsen Limited across four factors: quality 47/100, value 32/100. Its strongest factor is quality.
NXN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.50M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- AU$0.35
- 52-week low
- AU$0.11
- Avg volume (3M)
- —
- Shares outstanding
- 200.20M
- Employees
- —
- Next earnings
- —
About Nexsen Limited
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
- ISIN
- AU0000418782
- Founded
- 2021
- Listed since
- Oct 13, 2025
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BCAL Diagnostics LimitedASX: BDX | $20.15M | AU$0.08 | -12.22% |
| MDxHealth SANasdaqCM: MDXH | $19.71M | $0.21 | -64.97% |
| Modalis Therapeutics CorporationTSE: 4883 | $19.56M | ¥29.00 | -3.33% |
| Elicera Therapeutics AB (publ)OM: ELIC | $19.51M | Skr2.90 | +5.08% |
| Resverlogix Corp.TSX: RVX | $19.47M | CA$0.08 | -5.88% |
| Inhibitor Therapeutics, Inc.OTCPK: INTI | $19.10M | $0.11 | +12.14% |
| GenSight Biologics S.A.ENXTPA: SIGHT | $19.05M | €0.07 | -5.00% |
| HST Global, Inc.OTCPK: HSTC | $18.91M | $0.13 | -80.90% |
Figures last refreshed Oct 18, 2026.